- Home
- MDGL vs PSO Comparison
MDGL vs PSO Comparison
Compare MDGL & PSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | PSO |
|---|---|---|
| Founded | 2011 | 1844 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Books |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 9.8B |
| IPO Year | 2005 | 2000 |
Fundamental Metrics
Financial Performance| Metric | MDGL | PSO |
|---|---|---|
| Price | $459.63 | $17.86 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 19 | 2 |
| Target Price | ★ $685.78 | $15.70 |
| AVG Volume (30 Days) | 254.0K | ★ 656.8K |
| Earning Date | 11-03-2026 | 03-01-2027 |
| Dividend Yield | N/A | ★ 2.00% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $180,133,000.00 | N/A |
| Revenue This Year | $59.57 | $4.02 |
| Revenue Next Year | $38.84 | $4.65 |
| P/E Ratio | ★ N/A | $14.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $393.61 | $12.02 |
| 52 Week High | $615.00 | $17.75 |
Technical Indicators
Market Signals| Indicator | MDGL | PSO |
|---|---|---|
| Relative Strength Index (RSI) | 29.26 | 78.68 |
| Support Level | $455.42 | $15.94 |
| Resistance Level | $546.29 | N/A |
| Average True Range (ATR) | 16.54 | 0.22 |
| MACD | -4.18 | 0.18 |
| Stochastic Oscillator | 17.12 | 92.52 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About PSO Pearson Plc
UK-listed Pearson is a testing and educational provider. Pearson's primary operations are in assessment and qualifications, testing and higher education, but they also provide English education and testing, virtual learning, prehiring testing and screening, and upskilling/reskilling. The company divested noncore businesses, including the Financial Times, The Economist, and the publishing house Penguin, and is now focused on serving as an educational resource and testing provider.